Publications by authors named "G G Gregoriou"

Goal-directed behavior requires the effective suppression of distractions to focus on the task at hand. Although experimental evidence suggests that brain areas in the prefrontal and parietal lobe contribute to the selection of task-relevant and the suppression of task-irrelevant stimuli, how conspicuous distractors are encoded and effectively ignored remains poorly understood. We recorded neuronal responses from 2 regions in the prefrontal and parietal cortex of macaques, the frontal eye fields (FEFs) and the lateral intraparietal (LIP) area, during a visual search task, in the presence and absence of a salient distractor.

View Article and Find Full Text PDF
Article Synopsis
  • The hippocampus helps combine different pieces of information to support decision-making in uncertain situations, known as hidden state inference.
  • This study found that the ventral hippocampus is crucial for mice to perform well in a task that requires them to infer hidden states when choosing between two options.
  • The research highlights how hippocampal activity influences the differentiation of contexts and dopamine signaling, which are important for making optimized decisions.
View Article and Find Full Text PDF

While the physical signs of opioid withdrawal are most readily observable, withdrawal insidiously drives relapse and contributes to compulsive drug use, by disrupting emotional learning circuits. How these circuits become disrupted during withdrawal is poorly understood. Because amygdala neurons mediate relapse, and are highly opioid sensitive, we hypothesized that opioid withdrawal would induce adaptations in these neurons, opening a window of disrupted emotional learning circuit function.

View Article and Find Full Text PDF

Programmed cell death protein ligand-1 (PD-L1) expression in non-small cell lung cancer (NSCLC) tumors guides treatment selection. PD-L1 expression in circulating tumor cells (CTCs) may provide further information. We have explored PD-L1 and marker of proliferation Ki-67 (Ki67; also known as MKI67) in CTCs in longitudinal samples of 47 advanced NSCLC patients receiving pembrolizumab.

View Article and Find Full Text PDF